Riverside Insights (Riverside), a portfolio company of Alpine Investors (Alpine), has acquired ImPACT Applications, a provider of research-backed concussion assessments.ImPACT Applications will continue to operate under its current brand name and its products and services will continue to be offered to the thousands of healthcare providers, schools and organisations that it currently serves today. Mike Wahlster will remain as the leader of the business.
“With the acquisition of ImPACT, Alpine continues its strategy of catalyzing growth by supporting the partnership of complementary businesses within the education and healthcare industries,” says Daniel Cohen, Principal at Alpine Investors.
Both Riverside and ImPACT Applications are committed to delivering robust research-based assessment tools to educators and healthcare providers. Riverside is a market-leading provider of K-12 assessments for measuring student achievement as well as developmental and cognitive abilities. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
“The ImPACT Applications team has done an exceptional job of establishing itself as the gold standard in concussion assessments and management, while also driving customer growth across education, healthcare and sports organisations. Its commitment to high-quality research makes it a strong partner to Riverside’s mission to ‘Enrich 1 Billion Lives Globally By 2030’,” says Rajib Roy, CEO of Riverside.
“We are excited to partner with Riverside,” says Wahlster. “ImPACT Applications and Riverside both share the same vision for empowering customers with tools that are developed from world-class research and driving better outcomes for students and patients.”
Healthcare Growth Partners served as the financial advisor to ImPACT Applications.
